首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Acs pharmacology & translational science

缩写:

ISSN:N/A

e-ISSN:2575-9108

IF/分区:3.7/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1237
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Junna Mai,Heng Liang,Arabella H Wan et al. Junna Mai et al.
Tumor-associated macrophages (TAMs) critically shape the multiple myeloma (MM) microenvironment, yet the molecular programs linking immune signaling to MM dissemination remain unclear. Here, we identify a TAM-derived IL6-STAT3-PIM2-cMyc-FN1...
Navneet Kaur,Mary Jean Savitsky,Annie Scutte et al. Navneet Kaur et al.
Cancer remains one of the most significant global health challenges, characterized by an increasing incidence and mortality rate worldwide. In vitro models play a significant role in the initial investigations of cancer biology, drug screen...
Peiyan Zheng,Xiaowen Huang,Qing Wang et al. Peiyan Zheng et al.
Arachidonic acid (AA) and its metabolites play critical roles in inflammation and immune regulation, modulating the initiation, amplification, and resolution of inflammation. However, their comprehensive quantification remains a challenging...
Qing-Qing Ma,Hong-Zhang Cao,Ji-Hai Shi et al. Qing-Qing Ma et al.
To find potential biomarkers and related metabolic pathways based on metabonomics of rat joint tissue, the rats with stable collagen-induced arthritis (CIA) model were taken as the research object. A rat rheumatoid arthritis model was estab...
Emily Betancourt Fernández,Julia Baguña Torres,Raffaella Iurlaro et al. Emily Betancourt Fernández et al.
Leukemia Inhibitory Factor (LIF) is a pleiotropic cytokine secreted by tumor cells to evade immune detection, contributing to tumor progression and resistance to therapy. Targeting LIF has emerged as a promising strategy, with anti-LIF ther...
Sara S Rinne,Wen Yin,Ruonan Li et al. Sara S Rinne et al.
Overactive epidermal growth factor receptor (EGFR) signaling is often involved in driving different types of carcinomas. It is a well-studied target for targeted therapies, with both monoclonal antibodies and kinase inhibitors available for...
Pulakesh Pramanik,Bappa Maiti,Santanu Bhattacharya Pulakesh Pramanik
Xanthone, an oxygenated heterotricyclic phytochemical, has recently emerged as a promising scaffold in cancer research due to its multitargeted anticancer potential. Recent studies demonstrate its affinity for G-quadruplex (G4) DNA structur...
Yan Feng,Xiaoyan Wu,Ruiting Chen et al. Yan Feng et al.
Viral proteases are critical targets for antiviral drug development, but current screening methods for protease inhibitors often require high biosafety levels or lack cell-based relevance. Here, we developed a novel cell-based assay system ...
Kyriakos Georgiou,Antonios Kolocouris Kyriakos Georgiou
Class A G protein-coupled receptors (GPCRs) are targets for ∼36% of commercial drugs. GPCRs in their apo-forms exhibit conformational heterogeneity, and more than a single active and inactive conformation exists in equilibrium. Distinct tr...
Gargi Mukherjee,Neha Dutta,Muthumeena Ramanathan et al. Gargi Mukherjee et al.
Therapy-induced senescence (TIS) is a reversible growth arrest induced by anticancer treatments, which may contribute to the development of long-term therapy resistance in tumor cells. Senotherapeutics, agents targeting senescent cells, are...